Clinical Trial

A Clinical Study of HRS-8797 in Healthy Participants

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this phase I study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-8797 in healthy participants.
Trial Details
NCT Number NCT07698756
Lead Sponsor Chengdu Suncadia Medicine Co., Ltd.
Conditions Atopic Dermatitis
Enrollment 74 participants
Start Date 2026-07
Primary Completion 2026-12 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-13